Resultats globals: 1 registres trobats en 0.01 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
13 p, 575.7 KB Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My-LIFE European Delphi survey / Pozo-Rosich, Patricia (Universitat Autònoma de Barcelona) ; Gil-Gouveia, Raquel (Hospital da Luz (Lisboa, Portugal)) ; Donnet, Anne (Timone Hospital) ; Poole, Anne-Christine (Private Practice: Oslo Headache Centre) ; Gendolla, Astrid (Private Practice: Essen) ; Afridi, Shazia (Guy's and St Thomas' NHS Trust) ; Sanchez-De la Rosa, Rainel (Novartis Pharma AG) ; Terwindt, Gisela M. (Leiden University Medical Center) ; Tassorelli, Cristina (University of Pavia)
Clinical guidelines agree that preventive treatment should be considered in patients with uncontrolled migraine despite acute medications or patients with ≥4 migraine days per month. However, the criteria to define the effectiveness of treatment and the factors that inform the decision to (dis)continue it are not clearly defined in clinical practice. [...]
2021 - 10.1002/ejp.1831
European Journal of Pain (Regne Unit), Vol. 25 (july 2021) , p. 2177-2189  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.